Completed Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene NCT03602079 Conditions Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more Locations Florida Cancer Specialists & Research Institute — Sarasota, Florida, United States Beth Israel Deaconess Medical Center Cancer Center — Boston, Massachusetts, United States Karmanos Cancer Institute — Detroit, Michigan, United States Clinical Research Alliance, Inc. — Lake Success, New York, United States View more locations Show fewer locations Loading locations... View Trial Details
